Lam, et al. (2023)
Optimizing Lipid Nanoparticles for Delivery in Primates
Advanced Materials
DOI/10.1002/adma.202211420
Lam, et al. (2023)
Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications
Advanced Materials
DOI/epdf/10.1002/adma.202209624
Ye, et al. (2023)
Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection
Molecular Therapy
DOI.org/10.1016/j.ymthe.2022.09.009
Gatechompol (2022)
Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial
Nature Microbiology
DOI: 10.1038/s41564-022-01271-0
Prompetchara, et al. (2022)
Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice
Nature Communications
DOI: 10.1038/s41467-023-37795-0
Muramatsu, et al. (2022)
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine
Molecular Therapy
DOI: 10.1016/j.ymthe.2022.09.009
Parhiz, et al. (2022)
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
Journal of controlled Release
DOI: 10.1016/j.jconrel.2021.12.027
Holland, et al. (2021)
Ligand conjugate SAR and enhanced delivery in NHP
Molecular Therapy
DOI: https://doi.org/10.1016/j.ymthe.2021.06.002